Company Marimed Srl with Fiscal Code 17772544
recorded a turnover of 2024 of
18.851,
with a net profit of
4.599
and having an average number of employees of
- .
The company operates in the field of Închirierea şi subînchirierea bunurilor imobiliare proprii sau închiriate having the NACE code 6820.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Marimed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
48.604
28.322
48.078
12.340
16.956
14.416
16.155
25.526
22.999
18.851
Total Income - EUR
48.604
28.903
48.078
12.340
16.956
17.380
16.352
25.526
22.999
18.851
Total Expenses - EUR
2.050
7.364
11.129
9.814
9.071
14.198
6.069
19.391
22.693
13.325
Gross Profit/Loss - EUR
46.554
21.538
36.949
2.525
7.884
3.182
10.283
6.134
306
5.526
Net Profit/Loss - EUR
45.096
20.671
36.468
2.297
7.657
3.068
9.957
5.662
113
4.599
Employees
1
1
2
2
1
1
0
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -17.6%, from 22.999 euro in the year 2023, to 18.851 euro in 2024.
The Net Profit increased by 4.487 euro, from 113 euro in 2023, to 4.599 in the last year.
Check the financial reports for the company - Marimed Srl
Financial Rating - MARIMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Marimed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Marimed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Marimed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
4.490 euro in 2024 which includes Inventories of
55 euro, Receivables of
3.761 euro and cash availability of
674 euro.
The company's Equity was valued at
5.554 euro, while total Liabilities amounted to
105.530 euro.
Equity increased by 2.790 euro, from 2.779 euro in 2023, to 5.554 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Marimed Srl